학술논문
SEROLOGICAL RESPONSES AFTER SARS‐COV‐2 VACCINATION FIRST DOSE IN PATIENTS WITH LYMPHOID MALIGNANCY: FIRST INTERIM ANALYSIS OF THE UK PROSECO STUDY.
Document Type
Article
Author
Source
Hematological Oncology; Jun2021 Supplement S2, Vol. 39, p1-2, 2p
Subject
Language
ISSN
02780232